Smith & Nephew plc vs Xpeng Inc - ADR — how do they compare? Smith & Nephew plc trades at $30.45 (market cap $12.64B), while Xpeng Inc - ADR trades at $13.35 (market cap $12.96B). The key difference: Smith & Nephew plc and Xpeng Inc - ADR are close in size by market cap, and Smith & Nephew plc pays a 2.57% dividend while Xpeng Inc - ADR pays none. Which is the better fit depends on your goals.
| SNN | XPEV | |
|---|---|---|
Market Cap | $12.64B | $12.96B |
Sector | Health | Consumer Cyclical |
52-Week High | $38.70 | $28.07 |
52-Week Low | $28.73 | $12.09 |
Enterprise Value | $15.41B | $15.07B |
Dividend Yield | 2.57% | — |
Trailing returns across standard periods
Smith & Nephew designs, manufactures, and markets orthopedic devices, sports medicine and arthroscopic technologies, and wound-care solutions. Roughly 42% of the U.K.-based firm's revenue comes from orthopedic products, and another 30% is sports medicine and ENT. The remaining 28% of revenue is from the advanced wound therapy segment. Roughly half of Smith & Nephew's total revenue comes from the United States, just over 30% is from other developed markets, and emerging markets account for the remainder.
Read more on SNN →Founded in 2015, XPeng is a leading Chinese smart electric vehicle, or EV, company that designs, develops, manufactures and markets EVs in China. Its products primarily target the growing base of technology-savvy middle-class consumers in the midrange to high-end segment in China's passenger vehicle market. The company sold over 98,000 EVs in 2021, accounting for about 3% of China's passenger new energy vehicle market. It is also a leader in autonomous driving technology.
Read more on XPEV →